Archive
Proactive news snapshot: Alba Mineral Resources, Immotion Group, Pan African Resources …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
ImmuPharma PLC
LON:IMM
ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.
306 stories · page 7 of 16
Archive
Proactive news snapshot: Kromek, ITM Power, Rockfire Resources
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma updates status of talks over lead drug alongside reorganisation
The firm remains in conversation with potential commercial partners as well as its regulatory advisors
Investments and investor services
System1 Group pulls out of tailspin
A look at the day's major movers, including Energean Oil and Gas, Kier Group, Spectra Systems, Mayan Energy, Ascent Resources and Emmerson
Archive
Proactive news snapshot: SigmaRoc, Summit Therapeutics, Immotion Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Immotion to install its virtual reality pods at two major US aquariums
Immotion will install a range of VR cinematic motion pods on a revenue-share basis at Odysea Aquarium, in Scottsdale, Arizona, and The Maritime Aquarium, in Norwalk, Connecticut
Investments and investor services
FTSE 100 closes flat as traders don't know which way to turn
Footsie closed down around 0.19 at 7,436, while mid-cap FTSE 250 was up around 95 points at 19,807
Investments and investor services
Versarien boosted by completion of Graphene Council's "Verified Graphene Producer" programme
A look at the day's major movers, including Edenville Energy, Beowulf, Panthera Resources, Management Resource Solutions, Independent Oil & Gas, Block Energy, Highlands Natural Resources and Reabold Resources
Archive
Proactive news snapshot: Iofina, Circassia Pharma, Directa Plus, Instem …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma cancer programme talks continue
Conversations with Incanthera are continuing even though an extended period of exclusivity has lapsed
Archive
Proactive news snapshot: NetScientific, Capital Drilling, Horizonte Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
RedT Energy Storage shares plunge as it announces strategic review and equity raise
A look at some of the top risers and fallers in London on Thursday.
ImmuPharma continues to engage with potential corporate partners for Lupuzor, its late-stage treatment for Lupus
The firm said that following the conclusion of the pivotal Phase III trial earlier in 2018, it continues to look at opportunities which, over the longer term, have the potential of bringing Lupuzor to market
Archive
FTSE 100 closes higher as no deal Brexit fears ease
Footsie closed around 26 points higher at 7,185, while FTSE 250 added around 103 points at 19,283
XLMedia and Serinus Energy among Tuesday’s small-cap losers
A look at the day's major movers, including Persimmon, Quadrise Fuels International, Travis Perkins, and Babcock
Archive
Proactive news snapshot: Amur Minerals, Ormonde Mining, Europa Oil & Gas …
A glance at some of the day's highlights from the Proactive Investors newswire
ImmuPharma says article shines light on potential of peptide subsidiary
Peptide drugs generated US$30bn in sales last year
FTSE 100 closes lower as Brexit is talk of the town
Footsie closed down around 32 points at 7,151, while the FTSE 250 added 23 at 19,270
ImmuPharma continues to build data package for flagship lupus treatment
Results from a 62-patient follow-up study are due shortly, while data from a 500-person-strong managed access programme should be available by the end of next year